Consensus West Pharmaceutical Services, Inc. Xetra

Equities

WPS

US9553061055

Market Closed - Xetra Other stock markets 16:35:41 25/10/2023 BST			After market 21:00:01
342.5 ^EUR	-1.69%		311.2	-9.14%

06-13	West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	MT
06-04	Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM

Evolution of the average Target Price on West Pharmaceutical Services, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b421512ad.CKRDdZ42EiR-KgcsCmM6-McomElIuP58lO_eulA1_sc.Z4k6DOdVYFBNSz51OTAOootR_gQwla0v0d6q6BldvbB5yisyp297RQp5Tg~aecd69e5f351f7f2b00310c4e2dcfd37

Analyst Recommendations on West Pharmaceutical Services, Inc.

West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	06-13	MT
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing	05-09	MT
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	04-26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	04-26	MT
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	04-25	MT
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	02-16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	02-16	MT
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	02-16
KeyBanc Adjusts West Pharmaceutical Services Price Target to $470 From $440, Maintains Overweight Rating	02-13	MT
Jefferies Upgrades West Pharmaceutical Services to Buy From Hold, Adjusts Price Target to $536 From $323	02-07	MT
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	02-07
ANALYST RECOMMENDATIONS : Abbvie, Burberry, Chevron, Cisco, M&S...	11-16
Stephens Lowers Price Target on West Pharmaceutical Services to $390 From $420, Maintains Overweight Rating	27/10/23	MT
Deutsche Bank Cuts West Pharmaceutical Services Price Target to $350 From $360, Maintains Hold Rating	27/10/23	MT
Keybanc Adjusts Price Target on West Pharmaceutical Services to $440 From $415, Maintains Overweight Rating	30/08/23	MT
KeyBanc Adjusts West Pharmaceutical Services' Price Target to $415 From $385, Keeps Overweight Rating	21/08/23	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $360 From $290, Maintains Hold Rating	20/07/23	MT
Stephens Adjusts West Pharmaceutical Services' Price Target to $420 From $400, Keeps Overweight Rating	17/07/23	MT
UBS Adjusts Price Target on West Pharmaceutical Services to $400 From $365, Maintains Neutral Rating	10/07/23	MT
BofA Securities Upgrades West Pharmaceutical Services to Buy From Neutral, Raises Price Target to $405 From $390	16/06/23	MT
UBS Adjusts West Pharmaceutical Services Price Target to $365 From $356, Maintains Neutral Rating	28/04/23	MT
Stephens Upgrades West Pharmaceutical Services to Overweight From Equalweight, Raises Price Target to $400 From $330	11/04/23	MT
UBS Raises Price Target on West Pharmaceutical Services to $356 From $324, Keeps Neutral Rating	10/04/23	MT
UBS Adjusts West Pharmaceutical Services Price Target to $324 From $250, Maintains Neutral Rating	24/02/23	MT
Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $290 From $250, Maintains Hold Rating	22/02/23	MT